Literature DB >> 9861499

Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.

D W Scott1, K E Beningo, W H Miller, E Rothstein.   

Abstract

Clindamycin hydrochloride capsules (11 mg/kg body weight, q24 h) were administered orally to 20 dogs with deep staphylococcal pyoderma. Response to therapy was excellent in 100% of the dogs. Duration of therapy varied from 21 to 91 d, with an average duration of 45 d. Relapses occurred in 25% of the dogs within a 3-month period. One dog vomited when the clindamycin was given on an empty stomach. Under the conditions of the study, clindamycin was an effective, safe, and convenient antibiotic for the treatment of deep staphylococcal pyoderma in dogs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861499      PMCID: PMC1540377     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  16 in total

1.  Sensitivity of bacteria to 16 antibiotic agents.

Authors:  H E Rhoades
Journal:  Vet Med Small Anim Clin       Date:  1979-07

2.  Pharmacologic features of clindamycin in dogs and cats.

Authors:  J Harari; J Lincoln
Journal:  J Am Vet Med Assoc       Date:  1989-07-01       Impact factor: 1.936

3.  Antimicrobial susceptibility patterns of canine Staphylococcus intermedius isolates from veterinary clinical specimens.

Authors:  W E Phillips; B J Williams
Journal:  Am J Vet Res       Date:  1984-11       Impact factor: 1.156

4.  In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance.

Authors:  D Greenwood
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

5.  Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections.

Authors:  P M Tulkens
Journal:  Scand J Infect Dis Suppl       Date:  1990

Review 6.  Practical small animal dermatology. III: Bacterial disease.

Authors:  O M Briggs
Journal:  J S Afr Vet Assoc       Date:  1988-09       Impact factor: 1.474

7.  Antibiogram and production of beta-lactamase by canine isolates of Staphylococcus aureus.

Authors:  A Engvall; M Wierup
Journal:  Nord Vet Med       Date:  1982 Jan-Feb

8.  Frequency and antimicrobial susceptibility of Staphylococcus species isolated from canine pyodermas.

Authors:  L Medleau; R E Long; J Brown; W H Miller
Journal:  Am J Vet Res       Date:  1986-02       Impact factor: 1.156

9.  Antimicrobial susceptibility of coagulase-positive staphylococci isolated from Louisiana dogs.

Authors:  H U Cox; J D Hoskins; A F Roy; S S Newman; D G Luther
Journal:  Am J Vet Res       Date:  1984-10       Impact factor: 1.156

10.  Hepatic tuberculosis: comparison of miliary and local form.

Authors:  R N Chien; P Y Lin; Y F Liaw
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

View more
  2 in total

1.  Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs.

Authors:  Danny W Scott; Jeanine Peters; William H Miller
Journal:  Can Vet J       Date:  2006-10       Impact factor: 1.008

2.  Efficacy of anti-staphylococcal protein P128 for the treatment of canine pyoderma: potential applications.

Authors:  Raghu Patil Junjappa; Srividya Narayanamurthy Desai; Panchali Roy; Nagalakshmi Narasimhaswamy; Juliet Roshini Mohan Raj; Murali Durgaiah; Aradhana Vipra; Udaya Ravi Bhat; Smitha Komarla Satyanarayana; Nandini Shankara; Suneelkumar Muragesh Basingi; Jagadeesh Janardhan Bhat; Sukumar Hariharan; Bharathi Sriram; Sriram Padmanabhan
Journal:  Vet Res Commun       Date:  2013-05-10       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.